SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-16-011159
Filing Date
2016-07-01
Accepted
2016-07-01 17:15:20
Documents
8
Period of Report
2016-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctix_8k.htm 8-K 25562
2 EMPLOYMENT AGREEMENT ctix_ex101.htm EX-10.1 86481
3 CELLCEUTIX CORPORATION 2016 EQUITY INCENTIVE PLAN ctix_ex102.htm EX-10.2 126469
4 FORM OF INCENTIVE STOCK OPTION AGREEMENT ctix_ex103.htm EX-10.3 27268
5 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT ctix_ex104.htm EX-10.4 25489
6 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT ctix_ex105.htm EX-10.5 24468
7 FORM OF RESTRICTED STOCK AWARD AGREEMENT ctix_ex106.htm EX-10.6 23766
8 FORM OF RESTRICTED STOCK AWARD AGREEMENT ctix_ex107.htm EX-10.7 23431
  Complete submission text file 0001477932-16-011159.txt   364258
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 161747627
SIC: 2834 Pharmaceutical Preparations